Have a Claim?

Click here for a confidential contact or call:


November 20, 2014

Posted  January 26, 2016

The SEC suspended trading in four companies that claim to be developing products or services in response to the Ebola outbreak, citing a lack of publicly available information about the companies’ operations.  The SEC simultaneously issued an investor alert warning about the potential for fraud in microcap companies purportedly involved in Ebola prevention, testing, or treatment, noting that scam artists often exploit the latest crisis in the news cycle to lure investors into supposedly promising investment opportunities.  The companies whose trading was suspended were Bravo Enterprises Ltd., Immunotech Laboratories Inc.,Myriad Interactive Media Inc. and Wholehealth Products Inc.  SEC

Tagged in: Securities Fraud,